Asthma : Tunisian Society of RespiratoryDiseases and Allergology Guidelines

##plugins.themes.academic_pro.article.sidebar##

Published Mar 15, 2018
Download
pdf
Vol. 95 No. 8 (2017): Issue Aug 2017

##plugins.themes.academic_pro.article.main##

Agnès Hamzaoui
Karim Rekik
Sonia Maalej
Anissa Berraies
Maher Abouda
Nadia Mhiri
Neila Zalila
Jouda Cherif
Raoudha Boussofara
Insaf Ben Jrad
Farès Mili
Abdelwaheb Fekih
Majed Béji
Fatma Tritar
Mohamed Ridha Charfi

##plugins.themes.academic_pro.article.details##

References

  1. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000 Oct 12;343(15):1054-63.
  2. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med. 1997;337(20):1405-11.
  3. Kelly HW. Inhaled corticosteroid dosing: double for nothing? J Allergy ClinImmunol. 2011;128(2):278-281.e2.
  4. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy ClinImmunol. 2002;109(3):410-8.
  5. Masoli M, Holt S, Weatherall M, Beasley R. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. EurRespir J. 2004 Apr 1;23(4):552-8.
  6. Lemanske RF, Mauger DT, Sorkness CA, Jackson DJ, Boehmer SJ, Martinez FD, et al. Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med. 2010;362(11):975-85.
  7. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM. The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest. 2006;129(1):15-26.
  8. Cates CJ, Cates MJ. Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane database Syst Rev. 2008;(3):CD006363.
  9. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy ClinImmunol. 2006;117(1):45-52.
  10. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. EurRespir J. 2013;43(4):343-73.
  11. Burks a W, Calderon M a, Casale T, Cox L, Demoly P, Jutel M, et al. Update on allergy immunotherapy: American Academy of Allergy, Asthma &Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report. J Allergy ClinImmunol; 2013;131(5):1288-1296.e3.
  12. Kew KM, Karner C, Mindus SM, Ferrara G. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. Cochrane database Syst Rev. 2013 Jan;12(12):CD009019.
  13. Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, et al. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. Lancet Respir Med. 2013; 1(1):32-42.
  14. Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, et al. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial. Lancet Respir Med.; 2013;1(1):23-31.
  15. Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane databaseSystRev. 2003 Jan;(1):CD001117.
  16. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, et al. An official American Thoracic Society/EuropeanRespiratory Society statement: asthmacontrol and exacerbations: standardizingendpoints for clinicalasthma trials and clinical practice. Am J RespirCrit Care Med. 2009 ;180(1):59-99.
  17. Yoon HJ. Intermittent to mildasthma: the need for continuedtreatment. AllergyAsthmaImmunolRes. 2013 Nov;5(6):341-2.
  18. Szefler SJ. Advances in pediatricasthmain 2013: coordinatingasthma care. J Allergy ClinImmunol. 2014;133(3):654-61.
  19. Lougheed MD, Lemière C, Dell SD, et al. Canadian Thoracic Society Continuum de prise en charge de l'asthme de la Sociétécanadienne de thoracologie - Résumé du consensus de 2010 pour les enfants de six ans et pluset les adultes. Can Respir J 2010;17(1):15-24.
  20. Haute Autorité de Santé/SP2A. Asthme de l'enfant de moins de 36 mois : diagnostic, prise en charge et traitement en dehors des épisodesaigus. Mars 2009